Forum Discussions
These novel Fora, in WEF-style format, will bring together corporate participants, neuroscientists and clinicians with outstanding experience in “hottest” research topics in the field of neurodegeneration to discuss the impact of newest preclinical results and cutting edge clinical findings on understanding and treatment development of neurodegenerative disorders. The objective is to exchange novel insights, challenges and solutions on the joint path forward to defining the future of Alzheimer’s and Parkinson’s therapeutics.
Each forum will be 60 minutes moderated discussion with maximum 3 minutes introduction statement from each participant followed by questions from the audience submitted via Ask the Speaker function in the mobile APP and introduced to the discussion by the moderator. The forum is also open for journalists from different media, including lay press in and may report on progress made by the leaders in this field.
Then followed by the session:
FORUM: RESULTS OF THE DIAN-TU PREVENTION TRIAL OF SOLANEZUMAB AND GANTENERUMAB IN DOMINANTLY INHERITED AD
02 April 2020
16:00 – 16:50
Moderator: Roger Nitsch, Switzerland
Discussants:
Laurie Ryan, USA
M. Carrillo, USA
R. Bateman, USA
R. Yaari, USA
R. Doody, Switzerland
FORUM DISCUSSION 1: APPLICATIONS OF NEUROPSYCHOLOGY, PET, MRI, EEG, AND CSF FOR DIAGNOSIS AND ASSESSMENT OF TREATMENT EFFECTS
02 April 2020
17:00 – 18:00
Moderators: Henrik Zetterberg, Sweden; Angela Genge, Canada
Discussants:
T. Babic, Austria
J. Beaver, USA
T. Bittner, Switzerland
A. Nordberg, Sweden
G. Rabinovici, USA
FORUM DISCUSSION 2: TRANSLATIONAL DRUG DISCOVERY IN PD/ LBD PHASE I-III
03 April 2020
16:00 – 17:00
Moderators: Jamie Eberling, USA; Walter Koroshetz, USA
Discussants:
D. Aarsland, Norway
B. Mollenhauer,Germany
T. Ferguson, USA
F. Stocchi, Italy
FORUM DISCUSSION 3: TRANSLATIONAL DRUG DISCOVERY IN AD: LEARNING FROM FAILURES AND SUCCESSES
04 April 2020
17:00 – 18:10
Moderators: Rudolph Tanzi, USA; Ezio Giacobini, Switzerland
Discussants:
R. Bateman, USA
S. Budd-Haeberlein, USA
G. Gold, Switzerland
S. Koch, USA
L. Kulic, Switzerland
E. Masliah, USA
M.Windisch, Austria
